PF-06651600 Taste Study.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE2
Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China
- Status
- COMPLETED
- Phase
- PHASE2
LORA-PITA IV General Investigation
- Status
- COMPLETED
- Phase
- N/A
CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pneumonia Research and Vaccine Impact League
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
- Status
- COMPLETED
- Phase
- N/A
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
- Status
- COMPLETED
- Phase
- N/A
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
- Status
- COMPLETED
- Phase
- N/A
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1